Medicare also has precedent on its side regarding coverage of other medical products developed for Alzheimer’s patients. Aduhelm isn’t the first medical product associated with Alzheimer’s disease that has been subject to a CED, said Sean Dickson, director of health policy at the West Health Policy Center.
Around 112 million Americans have trouble paying for health care, while more than 90 percent of the country believes it is not worth the cost. The data was collected by Gallup and West Health through the Healthcare Affordability Index and Healthcare Value Index
Aduhelm’s price drop in December was a windfall for providers in the first quarter of this year because Medicare was still reimbursing them the previous price plus the add-on payment, according to Sean Dickson, director of health policy for West Health.
CMS should subtract rebates and pharmacy fees from the prices that Medicare beneficiaries pay for drugs, but it should count them when calculating Part D coverage phases, according to West Health Policy Center.
The venture will eventually be self-sustaining, said Shelley Lyford, vice chair of Civica Rx’s board. It will initially produce enough insulin to cover about 30% of the market.
The consortium’s nonprofit company, Civica Rx, said Thursday it plans to manufacture and sell generic versions of insulin at no more than $30 per vial and $55 for five injector-pen cartridges, a fraction of list prices that currently range from $125 to more than $500.
Non-profit drugmaker Civica said on Thursday it expects to launch lower-cost versions of insulin in the United States by 2024, to help diabetic patients struggling with high prices for the life-sustaining medicine.
And that’s just what nonprofit generic drugmaker Civica is looking to do, with plans to manufacture and market three of the most common forms of insulin: glargine, lispro and aspart. Perhaps most importantly, the company says it plans to set the price of each insulin to the consumer at no more than $30 per vial and no more than $55 for a box of five pen cartridges.
Nearly seven in 10 Black adults and Hispanic adults are very or somewhat stressed about contracting COVID-19, compared with 57% of White adults, according to a survey by West Health and Gallup.
A West Health and Gallup poll released this morning highlights the country’s longstanding health disparities, which the pandemic has further exacerbated.
